Twin Tree Management LP Purchases 27,653 Shares of Align Technology, Inc. $ALGN

Twin Tree Management LP lifted its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 611.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,177 shares of the medical equipment provider’s stock after buying an additional 27,653 shares during the period. Twin Tree Management LP’s holdings in Align Technology were worth $6,092,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in ALGN. Ninety One UK Ltd grew its position in Align Technology by 58.7% during the 1st quarter. Ninety One UK Ltd now owns 1,937,555 shares of the medical equipment provider’s stock worth $307,800,000 after acquiring an additional 716,954 shares during the last quarter. Federated Hermes Inc. boosted its stake in shares of Align Technology by 510.3% during the first quarter. Federated Hermes Inc. now owns 707,514 shares of the medical equipment provider’s stock valued at $112,396,000 after purchasing an additional 591,588 shares during the period. Mackenzie Financial Corp grew its holdings in shares of Align Technology by 4,217.3% in the first quarter. Mackenzie Financial Corp now owns 426,205 shares of the medical equipment provider’s stock worth $67,707,000 after purchasing an additional 416,333 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Align Technology by 104.2% in the first quarter. AQR Capital Management LLC now owns 404,310 shares of the medical equipment provider’s stock worth $63,133,000 after purchasing an additional 206,308 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Align Technology by 32.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 832,313 shares of the medical equipment provider’s stock valued at $132,221,000 after buying an additional 202,616 shares during the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Mizuho decreased their price objective on shares of Align Technology from $210.00 to $170.00 and set an “outperform” rating on the stock in a research report on Monday. Jefferies Financial Group reiterated a “hold” rating and issued a $140.00 price objective (down previously from $215.00) on shares of Align Technology in a report on Friday, October 10th. Leerink Partners lowered their target price on shares of Align Technology from $188.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday. Wells Fargo & Company dropped their price target on shares of Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a research note on Thursday, July 31st. Finally, Stifel Nicolaus dropped their target price on shares of Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a research note on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $187.67.

Insider Buying and Selling

In other Align Technology news, CEO Joseph M. Hogan purchased 7,576 shares of the firm’s stock in a transaction on Friday, August 1st. The shares were acquired at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the transaction, the chief executive officer owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.66% of the company’s stock.

Align Technology Stock Performance

Align Technology stock opened at $128.43 on Thursday. Align Technology, Inc. has a one year low of $122.00 and a one year high of $246.19. The stock has a fifty day moving average of $135.08 and a 200 day moving average of $163.69. The stock has a market cap of $9.31 billion, a PE ratio of 21.66, a price-to-earnings-growth ratio of 1.47 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the firm earned $2.41 earnings per share. The company’s revenue for the quarter was down 1.6% compared to the same quarter last year. Align Technology has set its Q3 2025 guidance at EPS. As a group, sell-side analysts predict that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology declared that its Board of Directors has initiated a share buyback plan on Tuesday, August 5th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to purchase up to 2% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its stock is undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.